Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Gemfibrozil products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A fibrate used to lower high triglyceride and cholesterol levels.
Products affected
1 / 3
In shortage since
May 29, 2024
Reports on file
11
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TEVA-GEMFIBROZIL
600MG · TABLET · TEVA CANADA LIMITED
DIN 02142074 · since May 29, 2024, no end estimate · Disruption of the manufacture of the drug.
Resolved
TEVA-GEMFIBROZIL
600MG · TABLET · TEVA CANADA LIMITED
DIN 02142074 · ended Aug 17, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-GEMFIBROZIL
600MG · TABLET · TEVA CANADA LIMITED
DIN 02142074 · ended Jul 14, 2021 · Demand increase for the drug.
Resolved
TEVA-GEMFIBROZIL
600MG · TABLET · TEVA CANADA LIMITED
DIN 02142074 · ended Jan 20, 2021 · Disruption of the manufacture of the drug.
Resolved
TEVA-GEMFIBROZIL
600MG · TABLET · TEVA CANADA LIMITED
DIN 02142074 · ended Jul 8, 2020 · Disruption of the manufacture of the drug.
Resolved
APO-GEMFIBROZIL
600MG · TABLET · APOTEX INC
DIN 01979582 · ended May 6, 2019 · Disruption of the manufacture of the drug.
Discontinued
APO-GEMFIBROZIL CAP 300MG USP
APOTEX INC
DIN 01979574
Resolved
APO-GEMFIBROZIL CAP 300MG USP
300 MG · CAPSULE · APOTEX INC
DIN 01979574 · ended Jun 3, 2019 · Disruption of the manufacture of the drug.
Discontinued
APO-GEMFIBROZIL CAP 300MG USP
300MG · CAPSULE · APOTEX INC
DIN 01979574
Resolved
TEVA-GEMFIBROZIL
600MG · TABLET · TEVA CANADA LIMITED
DIN 02142074 · ended May 1, 2018 · Disruption of the manufacture of the drug.
Discontinued
APO-GEMFIBROZIL
600MG · TABLET · APOTEX INC
DIN 01979582
What's happening
Gemfibrozil is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Gemfibrozil is classified under “LIPID MODIFYING AGENTS, PLAIN” (ATC C10AB).
Recent changes
No changes recorded yet.
Common questions
What is Gemfibrozil used for?
A fibrate used to lower high triglyceride and cholesterol levels.
When will Gemfibrozil be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Gemfibrozil in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.